Better Experiences in Substance Treatment: A Brief Alcohol-focused Intervention Tailored for Patients in Opioid Agonist Treatment
Better Experiences in Substance Treatment: A Brief Alcohol-Focused Intervention Tailored for Patients in Opioid Agonist Treatment
University of Notre Dame
60 participants
Jan 21, 2026
INTERVENTIONAL
Conditions
Summary
This study will help determine the feasibility and acceptability of a brief opioid-informed alcohol intervention in patients receiving prescribed buprenorphine for opioid use who are currently drinking alcohol. It will also provide initial information on whether the intervention improves outcomes related to alcohol use. The results of this proof-of-concept study will inform whether a future larger clinical trial is warranted.
Eligibility
Inclusion Criteria5
- Participants must be taking prescribed buprenorphine for at least 2 weeks
- Participants must be 18 years or older.
- Meet DSM-5 criteria for alcohol use disorder (AUD)
- Participants must report alcohol use ≥ 1 day/week on average in the past 28 days
- Participants must be able to read simple English
Exclusion Criteria1
- Currently receiving formal alcohol use treatment.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The brief opioid-informed alcohol treatment is based upon principles of Motivation Enhancement Therapy (MET) and Cognitive Behavioral Therapy (CBT) tailored to the needs of patients in opioid treatment. Participants will attend weekly in-person sessions for four weeks.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07342504